GoHealth Reports Second Quarter 2020 Results and Provides 2020 Outlook Growth Fueled by Strong Medicare Advantage Enrollments CHICAGO

GoHealth Reports Second Quarter 2020 Results and Provides 2020 Outlook

Growth Fueled by Strong Medicare Advantage Enrollments

CHICAGO, August 19, 2020 GoHealth, Inc. ( GoHealth ) (Nasdaq: GOCO), a leading health insurance marketplace, announced financial results

for the three and six months ended June 30, 2020.

The Company also provided a full year 2020 outlook, including net revenues of $840-890 million and adjusted

EBITDA1 of $265-290 million.

Clint Jones, co-founder and CEO said, We delivered 71% revenue growth in the second quarter, powered by strong Medicare Advantage

enrollments. Our strategic focus on LTV/CAC ensures that these high rates of growth convert into industry-leading margins and strong cash returns. Given the trajectory of our business and the investments we have been making in our direct-to-consumer

marketplace, we believe we are on track for another record year of results in fiscal 2020.

Jones continued, GoHealth is

one of the largest enrollers of Medicare Advantage plans in the United States. Our targeted marketing efforts help spur seniors to evaluate their Medicare plans as we continue to expand our carrier offerings and geographic footprint. The COVID-19 pandemic has accelerated the shift from traditional field agents to our technology enabled model, as consumers seek the expert advice of our agents from the comfort and safety of their homes. Importantly,

we are rapidly scaling up in a fast growing, 60 million plus person market where our larger scale and leadership position will allow us to better help both consumers and carriers.

Year-to-date highlights

The trajectory of the US economy remains challenging to predict, particularly given the heightened uncertainty associated with the COVID-19 pandemic. During these times, demand for healthcare has demonstrated great resilience, and we believe that the COVID-19 pandemic has created favorable industry

dynamics for technology-driven direct-to-consumer models such as GoHealth s insurance marketplace. The Company is providing an outlook for the fiscal year ending

December 31, 2020 based on current market conditions and expectations:

1. Full year 2020 net revenue of $840 $890 million,

representing year-over-year growth of 56% 65%

2. Full year 2020 adjusted EBITDA of $265 $290 million, representing

year-over-year growth of 55% 71%

Jones concluded, Our recent IPO marked an important milestone nearly two decades after Brandon Cruz and I founded the Company, providing

us with the necessary capital to deliver our long-term plan. We believe we have the winning strategy necessary to deliver great results for our shareholders over the coming years by working to improve access to healthcare in America.

Conference Call Details

The Company will host

a conference call today, Wednesday, August 19, 2020 at 5:00 pm (ET) to discuss its financial results. A live audio webcast and a supplemental presentation will be available online at https://investors.gohealth.com. The conference

call can also be accessed by dialing 1-833-519-1310 for U.S. participants, or 1-914-800-3876 for international participants, and referencing participant code 9537505. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link.

As a leading health insurance marketplace, GoHealth s mission is to improve access to healthcare in America. Enrolling in a health insurance plan can be

confusing for customers, and the seemingly small differences between plans can lead to significant out-of-pocket costs or lack of access to critical medicines and even

providers. GoHealth combines cutting-edge technology, data science and deep industry expertise to match customers with the healthcare policy and carrier that is best for them. Since its inception, GoHealth has enrolled millions of people in Medicare

and individual and family plans. For more information, visit https://www.gohealth.com

Adjusted EBITDA is a non-GAAP measure. For a definition of Adjusted EBITDA and a reconciliation to the most comparable GAAP measure, please refer to the appendix.

2 LTV/CAC defined as (i) aggregate commissions estimated to be collected over the estimated life of all Approved Submissions for the relevant period based on multiple factors, including but

not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints, or LTV, divided by (ii) the cost to convert a prospect into a customer less other

non-commission carrier revenue for such period, or CAC. 3 Total Medicare Advantage Submitted Policies includes Commissionable and non-Commissionable Policies.

Jay Koval, VP of Investor Relations

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than

statements of historical facts contained in this press release may be forward-looking statements. Statements regarding the Company s future results of operations and financial position, business strategy and plans and objectives of management

for future operations, including, among others, statements regarding expected financial performance and operational performance for the fiscal year 2020, including with respect to revenue and Adjusted EBITDA, are forward-looking statements. In some

cases, you can identify forward-looking statements by terms, such as may, will, should, expects, plans, anticipates, could, intends, targets,

projects, contemplates, believes, estimates, predicts, potential or continue or the negative of these terms or other similar expressions. Accordingly, we caution you

that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although the Company believes that the expectations reflected in these

forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. There are or will be important factors that could cause the

Company s actual results to differ materially from those indicated in these forward-looking statements, including, but are not limited to, the following: the Company s ability to comply with the numerous, complex and frequently changing

laws regulating the marketing and sale of Medicare plans; the potential for an adverse change in our relationships with carriers, including a loss of a carrier relationships; failure to grow the Company s customer base or retain our existing

customers; carriers ability to reduce commissions paid to the Company and adversely change their underwriting practices; significant consolidation in the healthcare industry which could adversely alter the Company s relationships with

carriers; information technology systems failures or capacity constraints interrupting the Company s operations; factors that adversely impact the Company s estimate of LTV; the Company s dependence on agents to sell insurance plans;

changes in the health insurance system and laws and regulation governing health insurance markets; the inability to effectively advertise the Company s products; and our ability to successfully implement our business plan during a global

economic downturn caused by the COVID-19 pandemic.

The foregoing factors should not be construed as exhaustive

and should be read together with the other cautionary statements included in this press release, as well as the cautionary statements and other risk factors set forth in the Company s Quarterly Report on Form

10-Q for the second quarter ended June 30, 2020 filed with the SEC. If one or more events related to these or other risks or uncertainties materialize, or if the Company s underlying assumptions

prove to be incorrect, actual results may differ materially from what the Company anticipates. Many of the important factors that will determine these results are beyond the Company s ability to control or predict. Accordingly, you should not

place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and, except as otherwise required by law, the Company does not undertake any obligation to publicly update or

review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact

of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Use of Non-GAAP Financial Measures and Key Performance Indicators

In this press release, we use supplemental measures of our performance that are derived from our consolidated financial information, but which are not

presented in our consolidated financial statements prepared in accordance with GAAP. These non-GAAP financial measures include net income (loss) before interest expense, income tax expense (benefit) and

depreciation and amortization expense, or EBITDA; Adjusted EBITDA and Adjusted EBITDA margin. Adjusted EBITDA is the primary financial performance measure used by management to evaluate its business and monitor its results of operations.

Adjusted EBITDA represents EBITDA as further adjusted for share-based compensation, change in fair value of earnout liability, Centerbridge Acquisition costs,

severance costs and incremental organizational costs in connection with the IPO. Adjusted EBITDA margin represents Adjusted EBITDA divided by net revenues.

We use non-GAAP financial measures to supplement financial

information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated

financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our

stakeholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period to period comparisons. There are limitations to

the use of the non-GAAP financial measures presented in this press release. For example, our non-GAAP financial measures may not be comparable to similarly titled

measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative

The non-GAAP financial measures are not meant to be considered as indicators of performance in

isolation from or as a substitute for net income (loss) prepared in accordance with GAAP, and should be read only in conjunction with financial information presented on a GAAP basis. Reconciliations of each of EBITDA and Adjusted EBITDA to its most

directly comparable GAAP financial measure, net income (loss), are presented in the tables below in this press release. We encourage you to review the reconciliations in conjunction with the presentation of the

non-GAAP financial measures for each of the periods presented. In future periods, we may exclude similar items, may incur income and expenses similar to these excluded items and include other expenses, costs

and non-recurring items.

Management has provided its outlook regarding adjusted EBITDA, which is a non-GAAP financial measures and exclude certain charges. Management has not reconciled these non-GAAP financial measures to the corresponding GAAP financial measures because

guidance for the various reconciling items are not provided. Management is unable to provide guidance for these reconciling items because we cannot determine their probable significance, as certain items are outside of the company s control and

cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.

LTV/CAC refers to the Lifetime Value of Commissions per Consumer Acquisition Cost, which we define as (i) aggregate commissions estimated to

be collected over the estimated life of all commissionable Approved Submissions for the relevant period based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied

constraints, or LTV, divided by (ii) the cost to convert a prospect into a customer less other noncommission carrier revenue for such period, or CAC. CAC is comprised of cost of revenue, marketing and advertising expenses and customer care and

enrollment expenses less other revenue and is presented on a per commissionable Approved Submission basis. Approved Submissions refer to Submitted Policies approved by carriers for the identified product during the indicated period.

LTV Per Approved Submission refers to the Lifetime Value of Commissions per Approved Submission, which we define as (i) aggregate commissions estimated to be collected over the estimated life of all commissionable Approved

Submissions for the relevant period based on multiple factors, including but not limited to, contracted commission rates, carrier mix and expected policy persistency with applied constraints, divided by (ii) the number of commissionable

Approved Submissions for such period.

The following table sets forth the components of our results of operations for the three months ended

June 30, 2020 and 2019 (unaudited):

The reconciliations of GAAP net (loss) income to EBITDA and Adjusted EBITDA for the three months ended

June 30, 2020 and 2019 are as follows:

The following table sets forth the components of our results of operations for the six months ended

June 30, 2020 and 2019 (unaudited):

The reconciliations of GAAP net (loss) income to EBITDA and Adjusted EBITDA for the six months ended

June 30, 2020 and 2019 are as follows:

GoHealth Holdings, LLC and Subsidiaries

Condensed Consolidated Balance Sheets

(dollars in thousands, except unit and per unit amounts)